Oguz Kagan Bakkaloglu

4PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 22, 2026
Upadacitinib as a rescue therapy for steroid- and infliximab-refractory acute severe ulcerative colitis: short- and long-term effectiveness and safety in a multicenter cohort study.

|Dec 11, 2025
Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles.

Tugce Eskazan, Oguz Kagan Bakkaloglu, Murat Toruner

|Oct 25, 2021
Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study.

Oguz Kagan Bakkaloglu, Ozgen Yildirim, Bilger Cavus

|Oct 05, 2021
Can we predict mucosal remission in ulcerative colitis more precisely with a redefined cutoff level of C-reactive protein?

Oguz Kagan Bakkaloglu, Tugce Eskazan, Sinem Celik

Pageof 1

Frequent Collaborators

2 joint publications

Tugce Eskazan

1 joint publications

Murat Toruner

1 joint publications

Haluk Tarik Kani

1 joint publications

Bilger Cavus